Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Alligent Biopharm Consulting

Alligent Biopharm Consulting?uq=AFYHfsyn
2010 FOUNDED
M&A STATUS
21-30 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of medical affair agency services. The company develops and delivers integrated aligned medical communication services to the biopharma industry. It offers clinical trial design, data explorations, supported trial management, publication strategy, TL strategy, slide development and training and specializes in KOL strategy, medical content development and strategic meetings.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Other Healthcare
Other Healthcare Services
Parent Company
Primary Office
  • 331 Elm Street
  • Long Hill, NJ 07980
  • United States

+1 (908) 000-0000

Alligent Biopharm Consulting Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Alligent Biopharm Consulting‘s full profile, request access.

Request full access to PitchBook

Alligent Biopharm Consulting Executive Team (2)

Name Title Board
Seat
Contact
Info
David Thompson Partner & Managing Director
Joseph Kohles Ph.D Partner & Managing Director